Camden National Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.6M Sell
71,057
-1,251
-2% -$151K 1.24% 37
2025
Q1
$8.06M Sell
72,308
-1,201
-2% -$134K 1.2% 40
2024
Q4
$7.15M Sell
73,509
-429
-0.6% -$41.7K 1.07% 47
2024
Q3
$8.5M Sell
73,938
-1,444
-2% -$166K 1.22% 41
2024
Q2
$8.03M Buy
75,382
+10,290
+16% +$1.1M 1.24% 40
2024
Q1
$6.3M Sell
65,092
-1,403
-2% -$136K 1.11% 43
2023
Q4
$6.71M Sell
66,495
-541
-0.8% -$54.6K 1.25% 41
2023
Q3
$6.83M Sell
67,036
-491
-0.7% -$50K 1.4% 35
2023
Q2
$6.81M Sell
67,527
-1,174
-2% -$118K 1.33% 35
2023
Q1
$6.32M Buy
68,701
+519
+0.8% +$47.7K 1.28% 37
2022
Q4
$6.19M Sell
68,182
-261
-0.4% -$23.7K 1.29% 38
2022
Q3
$5.2M Buy
68,443
+308
+0.5% +$23.4K 1.16% 43
2022
Q2
$5.76M Buy
68,135
+1,724
+3% +$146K 1.19% 43
2022
Q1
$5.83M Buy
66,411
+285
+0.4% +$25K 1.06% 47
2021
Q4
$5.78M Sell
66,126
-488
-0.7% -$42.7K 1.02% 42
2021
Q3
$5.45M Buy
66,614
+1,439
+2% +$118K 1.05% 44
2021
Q2
$5.95M Sell
65,175
-614
-0.9% -$56K 1.12% 43
2021
Q1
$5.62M Sell
65,789
-619
-0.9% -$52.9K 1.12% 44
2020
Q4
$6.27M Sell
66,408
-2,528
-4% -$239K 1.3% 37
2020
Q3
$6M Buy
68,936
+536
+0.8% +$46.6K 1.32% 33
2020
Q2
$5.97M Buy
68,400
+167
+0.2% +$14.6K 1.48% 27
2020
Q1
$5.63M Sell
68,233
-8,806
-11% -$726K 1.53% 32
2019
Q4
$7.3M Buy
77,039
+2,619
+4% +$248K 1.48% 37
2019
Q3
$6.47M Buy
74,420
+809
+1% +$70.3K 1.41% 39
2019
Q2
$6.72M Sell
73,611
-7,899
-10% -$721K 1.55% 35
2019
Q1
$7.02M Buy
81,510
+867
+1% +$74.7K 1.7% 33
2018
Q4
$6.2M Buy
80,643
+4,249
+6% +$327K 1.71% 32
2018
Q3
$5.9M Buy
76,394
+2,844
+4% +$220K 1.45% 38
2018
Q2
$4.98M Buy
73,550
+7,350
+11% +$498K 1.31% 40
2018
Q1
$4.8M Buy
66,200
+1,074
+2% +$77.8K 1.39% 35
2017
Q4
$4.9M Buy
65,126
+1,055
+2% +$79.4K 1.42% 34
2017
Q3
$4.93M Buy
64,071
+2,091
+3% +$161K 1.46% 36
2017
Q2
$4.64M Buy
61,980
+5,326
+9% +$398K 1.42% 36
2017
Q1
$3.77M Buy
56,654
+2,845
+5% +$189K 1.16% 40
2016
Q4
$3.51M Buy
+53,809
New +$3.51M 1.08% 40